|
PRESS RELEASES
Contacts:
Anthony Viscogliosi, Small Bone Innovations,
Inc. (212) 583-9700 ext. 2100
Nick Kilsby, Creative Partners PR, (203) 705-9202
SBi LAUNCHES rHEAD™ LATERAL RADIAL HEAD IMPLANT and rHEAD™
PLATING SYSTEMS TO EXPAND ITS ELBOW MANAGEMENT SYSTEM
New York, NY: September 28, 2007 - Small
Bone Innovations, Inc. (SBI), a single-source provider of products,
technology and education for the small bone and joint orthopedic market
sector, announced today the launch of the rHead™ Lateral Radial
Head Implant System. To further augment its Elbow Management System,
the company also launched the rHead™ Plating System for internal
fixation of proximal radius fractures.
The rHead Lateral Implant is a side-loading radial head prosthesis that
allows for a minimally invasive approach and exposure in radial head
replacement surgery. The head and stem of the implant connect by the
means of a dove-tail locking mechanism that does not require a set screw
- saving time in the operating room.
The rHead implant and new plating systems have received 510(k) clearance
by the FDA. The rHead Lateral is indicated for treatment of arthritic
and traumatic conditions of the radial head.
Anthony G. Viscogliosi, Chairman & CEO of SBi, said: “The
addition of the rHead Lateral implant and the complementary new plating
system responds to surgeon demand for a full range of treatment options
for every disease stage or severity of trauma in the elbow.”
The stem of the rHead Lateral implant is plasma coated with titanium
for immediate stability in the canal and optimum osteo-integrating properties.
As with SBi’s existing rHead implants, the stem has a 12-degree
curve to match the anatomy of the radius.
This stem is available with a 2 mm standard collar or a 6 mm extended
collar.
“The modularity of treatment options now available from SBi is
making the often complicated alignment challenges in elbow repair or
reconstruction more manageable and predictable in outcome,” said
Amit Gupta, M.D, who completed the first procedure using the Lateral
rHead at the Louisville Arm and Hand Center.
“A unique feature of the system is the coupling mechanism between
the radial head and stem that enables the implant to be implanted sideways
to reduce ligament disruption,” Dr. Gupta added.
According to SBi, surgeons have been instrumental in creating the Elbow
Management System. The first rHead™ device was released in 1999
by Avanta (later acquired by SBi) and two years later a bi-polar version,
the rHead Recon was introduced.
This was followed last year with the introduction of the SBi UNI-Elbow
Radio Capitellum System™ as the first commercially available uni-compartmental
elbow arthroplasty system. The new rHead Lateral implant heads are approved
for use with the UNI-Elbow System for patients requiring a uni-compartmental
solution.
Surgeons using SBi’s Elbow Management System are also benefiting
from the company’s Precise Guidance Technology (PGT™) instrument
system that assists anatomical placement of the rHead implants. The
trialing system helps to size the implant to render it as minimally
invasive as is practicable.
The new rHead Lateral implant comes with an assembly tool for quick
engagement or disengagement of the head and stem. The accompanying impactor
tool is configured to assure precise positioning of the implant by referencing
the surrounding anatomy.
* * * * * * * * * * * * *
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi
Bros., LLC, (VB), the New York-based merchant banking firm that specializes
in the musculoskeletal/orthopedic sector. VB created SBi as the first
company to focus purely on small bone & joint science. By integrating
established companies and professionals in the field, SBi can offer
a broad, clinically proven portfolio of products and technologies to
treat trauma and diseases in small bones & joints. Today, SBi has
more than 140 employees at facilities in New York, NY, Morrisville,
PA and Minneapolis, MN.
SBi closed on the sale of $42.2 million of its securities in December
2005. At the time, based on data provided by Venture Source, this was
the largest venture capital investment ever recorded in the field of
orthopedic devices.
SBi was a 2006 recipient of Red Herring magazine's annual “"Red
Herring 100 North America" award, recognized as one of the nation's
leading technology companies and the only orthopedic device company
selected among an initial entry of more than one thousand firms.
Additionally, SBi's Artelon CMC-I Spacer, developed for patients with
thumb base osteoarthritis, was featured on the cover and highlighted
within Medical Design Technology magazine's “"Year of Innovation"
issue as one of the most fascinating technologies influencing the medical
device industry.
Medical Device & Diagnostic Industry Magazine named SBi to their
list of “"50 Companies to Watch" in 2006, noting, "Small
Bone Innovations is going against the grain in its determination to
become a market leader in the small bone & joint device sector."
For more information on SBi, please visit: www.totalsmallbone.com
About Viscogliosi Bros., LLC:
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB)
was the first venture capital/private equity and merchant banking firm
dedicated to the musculoskeletal/orthopedics sector of the health care
industry.
Today, VB is a leading independent firm with a mission to create, build
and finance companies founded on innovations developed by surgeons and
uniquely focused on "life changing" musculoskeletal/orthopedic
technologies. VB has worldwide surgeon, industry and trade relationships
and significant financial expertise in the musculoskeletal/orthopedic
sector.
As principals of VB, the Viscogliosi brothers have a combined total
of nearly half a century of experience analyzing and investing in the
musculoskeletal/orthopedics sector, directing literally billions of
dollars through the orthopedics industry. They have pioneered innovative
financial, strategic and management initiatives for nearly 150 companies
in the sector, from start-up, seed and development stage all the way
to exit, while helping thousands of people lead better lives through
the orthopedic and spinal products marketed and sold by the companies
they have assisted in developing and financing.
For more information on VB, go to: www.vbllc.com
Forward-looking statements
This press release may contain forward-looking statements as defined
in the U.S. Private Securities Litigation Reform Act of 1995. Readers
are cautioned not to place undue reliance on these forward-looking statements.
Actual results may differ materially from those indicated by these forward-looking
statements as a result of risks and uncertainties impacting the Company's
business including increased competition; the ability of the Company
to expand its operations and to attract and retain qualified professionals;
technological obsolescence; general economic conditions; and other risks.
Copyright © Small Bone Innovations, Inc., 2005-2006.
> Back to Press Releases
|
|
